• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国卫生研究院文献>Journal of Clinical and Translational Science >A multi-institutional partnership catalyzing the commercialization of medical devices and biotechnology products
【2h】

A multi-institutional partnership catalyzing the commercialization of medical devices and biotechnology products

机译：一种多机构伙伴关系催化医疗器械和生物技术产品的商业化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The commercialization of medical devices and biotechnology products is characterized by high failure rates and long development lead times particularly among start-up enterprises. To increase the success rate of these high-risk ventures, the University of Massachusetts Lowell (UML) and University of Massachusetts Medical School (UMMS) partnered to create key academic support centers with programs to accelerate entrepreneurship and innovation in this industry. In 2008, UML and UMMS founded the Massachusetts Medical Device Development Center (M2D2), which is a business and technology incubator that provides business planning, product prototyping, laboratory services, access to clinical testing, and ecosystem networking to medical device and biotech start-up firms. M2D2 has three physical locations that encompass approximately 40,000 square feet. Recently, M2D2 leveraged these resources to expand into new areas such as health security, point of care technologies for heart, lung, blood, and sleep disorders, and rapid diagnostics to detect SARS-CoV-2. Since its inception, M2D2 has vetted approximately 260 medical device and biotech start-up companies for inclusion in its programs and provided active support to more than 80 firms. This manuscript describes how two UMass campuses leveraged institutional, state, and Federal resources to create a thriving entrepreneurial environment for medical device and biotech companies.
机译：医疗器械和生物技术产品的商业化的特点是较高的失败率和较长的发展交通时间，特别是在初创企业中。为了增加这些高风险企业的成功率，马萨诸塞大学洛厄尔大学（UML）和马萨诸塞大学医学院（UMMS）合作，建立了与加速这个行业的企业家精神和创新的方案创建关键学术支持中心。 2008年，UML和UMMS创立了Massachusetts医疗器械开发中心（M2D2），这是一家商业和技术孵化器，提供业务规划，产品原型，实验室服务，进入医疗设备和生物技术的生态系统网络和生态系统公司。 M2D2有三个物理位置，包括大约40,000平方英尺。最近，M2D2利用这些资源扩展到新领域，如健康安全，心脏，肺，血液和睡眠障碍的护理技术点，以及检测SARS-COV-2的快速诊断。自成立以来，M2D2已审核大约260个医疗设备和生物技术启动公司，以包含在其计划中，并为80多家公司提供积极支持。此稿件描述了两种Umass校园利用机构，州和联邦资源如何为医疗设备和生物技术公司创造一个蓬勃发展的创业环境。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号